My Application Form Status

Check the status of your application form with Angel Broking.
Arq - The Hyper Intelligent Investment Engine By Angel Broking
IDFC heads north after RBI removes foreign investment curbs
Jun 22,2017

Meanwhile, the S&P BSE Sensex was up 180.31 points or 0.58% at 31,463.95. The S&P BSE Mid-Cap index rose 48.54 points or 0.33% at 14,899.28.

On the BSE, 7.81 lakh shares were traded on the counter so far as against the average daily volumes of 14.53 lakh shares in the past one quarter. The stock had hit a high of Rs 59.25 and a low of Rs 57.95 so far during the day. The stock had hit a 52-week high of Rs 71.20 on 26 October 2016 and a 52-week low of Rs 46.60 on 24 June 2016.

The stock had underperformed the market over the past one month till 21 June 2017, sliding 6.14% compared with the Sensexs 2.69% rise. The stock had also underperformed the market over the past one quarter, advancing 5.04% as against the Sensexs 6.1% rise. The scrip had underperformed the market over the past one year, gaining 13.35% as against the Sensexs 16.67% rise.

The mid-company has equity capital of Rs 1595.95 crore. Face value per share is Rs 10.

The Reserve Bank of India (RBI) yesterday, 21 June 2017 notified that the foreign shareholding by foreign institutional investors (FIIs)/foreign portfolio investors (FPIs) in IDFC have gone below the prescribed FII/FPI investment limit. Hence, the restrictions placed on the purchase of shares by FII/FPI of IDFC are withdrawn with immediate effect.

On consolidated basis, IDFCs net profit rose 3.3% to Rs 134.80 crore on 22.7% growth in total income to Rs 2577.88 crore in Q4 March 2017 over Q4 March 2016.

Post the demerger and transfer of the financing undertaking to IDFC Bank with effect from 1 October 2015, IDFC is mainly an investment company with minimal operations.

Powered by Capital Market - Live News

Graphite India hits record high on recent rally
Jun 22,2017

Meanwhile, the S&P BSE Sensex was up 181.63 points, or 0.58% at 31,465.27. The S&P BSE Small-Cap index was up 83.46 points, or 0.53% at 15,779.73.

High volumes were witnessed on the counter. On the BSE, 3.15 lakh shares were traded on the counter so far as against the average daily volumes of 61,603 shares in the past one quarter. The stock had hit a high of Rs 160.20 so far during the day, which is also its record high. The stock hit a low of Rs 149.25 so far during the day. The stock had hit a 52-week low of Rs 70.10 on 30 September 2016.

The stock had outperformed the market over the past one month till 21 June 2017, advancing 31.12% compared with the Sensexs 2.69% rise. The scrip had also outperformed the market over the past one quarter advancing 32.82% as against the Sensexs 6.1% rise. The scrip had also outperformed the market over the past one year advancing 98.2% as against the Sensexs 16.67% rise.

The small-cap company has equity capital of Rs 39.08 crore. Face value per share is Rs 2.

Shares of Graphite India surged 33.76% in eight trading sessions to its current ruling price of Rs 157.10, from a close of Rs 117.45 on 12 June 2017.

Graphite Indias net profit spurted 117% to Rs 61.97 crore on 7.2% increase in net sales to Rs 366.22 crore in Q4 March 2017 over Q4 March 2016.

Graphite India is engaged in the manufacture of graphite electrodes including carbon and graphite specialty products.

Powered by Capital Market - Live News

Mindtree advances after introducing new IT service
Jun 22,2017

The announcement was made after market hours yesterday, 21 June 2017.

Meanwhile, the S&P BSE Sensex was up 207.85 points, or 0.66%, to 31,491.49. The S&P BSE Mid-Cap index was up 81.97 points, or 0.55%, to 14,932.71.

On the BSE, 7,916 shares were traded in the counter so far, compared with average daily volume of 53,649 shares in the past one quarter. The stock had hit a high of Rs 529.95 and a low of Rs 519 so far during the day. The stock had hit a 52-week high of Rs 681.50 on 5 July 2016. The stock had hit a 52-week low of Rs 400 on 9 November 2016.

The stock had outperformed the market over the past one month till 21 June 2017, gaining 4.47% compared with 2.69% rise in the Sensex. The scrip had also outperformed the market in past one quarter, gaining 9.41% as against Sensexs 6.1% gains. The scrip had, however, underperformed the market in past one year, dropping 20.76% as against Sensexs 16.67% gains.

The mid-cap company has equity capital of Rs 168.03 crore. Face value per share is Rs 10.

Mindtree said that the service combines next-practice methods and tools to tightly integrate infrastructure and applications into a unified foundation that provides up to 30% cost savings from traditional operating models.

Integrated Services is powered by Mindtree CAPE, a customizable plug-and-play platform that integrates the enterprise technology landscape and accelerates the automation journey. It is equipped with converged capabilities of DevOps and Agile along with technologies like robotic process automation and cognitive computing.

Mindtree had announced on 19 June 2017 that its company, Magnet 360 announced the release of ConsumerConnect 36, a Salesforce Fullforce Solution Accelerator for consumer goods brands.

Mindtrees consolidated net profit fell 5.72% to Rs 97.20 crore on 1.76% rise in net sales to Rs 1318.10 crore in Q4 March 2017 over Q3 December 2016.

Mindtree delivers digital transformation and technology services from ideation to execution, enabling Global 2000 clients to outperform the competition.

Powered by Capital Market - Live News

Amtek Auto extends recent rally
Jun 22,2017

Meanwhile, the S&P BSE Sensex was up 210.83 points or 0.67% at 31,494.47. The S&P BSE Small-Cap index rose 102.77 points or 0.65% at 15,799.04.

On the BSE, 29.13 lakh shares were traded on the counter so far as against the average daily volumes of 7.40 lakh shares in the past one quarter. The stock had hit a high of Rs 30.95 and a low of Rs 30 so far during the day. The stock had hit a 52-week high of Rs 56.20 on 26 July 2016 and a 52-week low of Rs 21.25 on 20 June 2017.

The stock had underperformed the market over the past one month till 21 June 2017, sliding 23.09% compared with the Sensexs 2.69% rise. The stock had also underperformed the market over the past one quarter, declining 20.48% as against the Sensexs 6.1% rise. The scrip had also underperformed the market over the past one year, sliding 22.45% as against the Sensexs 16.67% rise.

The small-cap company has equity capital of Rs 49.65 crore. Face value per share is Rs 2.

Shares of Amtek Auto rallied 31.98% in three trading sessions to its ruling price, from its closing of Rs 23.45 on 19 June 2017. The rally in the stock was triggered by media reports that the company has received expressions of interest (EoIs) from 21 investors, including Bain Capital, TPG Capital, DA Capital, Piramal Enterprises, AION Capital, Deccan Value Investors and Edelweiss Asset Reconstruction Company which will place financial bids over the next three months for a stake in the debt-ridden auto component maker.

However, Amtek Auto in a clarification issued to the stock exchanges after market hours yesterday, 21 June 2017 said that presently it does not have any information which is required to be disclosed to stock exchanges. The company cited its earlier disclosures dated 30 November 2016 and 30 May 2017 wherein it had stated that the secured lenders to the company had already initiated process to seek substantial investments from the potential investors in the company.

Total promoter holding in Amtek Auto stood at 52.4% as per the shareholding pattern as on 10 April 2017.

Amtek Auto reported net loss of Rs 307.57 crore in Q4 March 2017, lower than net loss of Rs 563 crore in Q4 March 2016. Net sales declined 31.8% to Rs 442.36 crore in Q4 March 2017 over Q4 March 2016.

Amtek Auto is one of the leading integrated auto component manufacturers.

Powered by Capital Market - Live News

Nelco declines on profit booking
Jun 22,2017

Meanwhile, the S&P BSE Sensex was up 218.79 points, or 0.7% at 31,502.43. The S&P BSE Small-Cap index was up 111.78 points, or 0.71% at 15,808.05.

High volumes were witnessed on the counter. On the BSE, 1.14 lakh shares were traded on the counter so far as against the average daily volumes of 62,241 shares in the past one quarter. The stock had hit a high of Rs 103.70 and a low of Rs 99.45 so far during the day. The stock had hit a 52-week high of Rs 109.45 on 21 June 2017 and a 52-week low of Rs 68.40 on 22 November 2016.

The stock had outperformed the market over the past one month till 21 June 2017, advancing 28.24% compared with the Sensexs 2.69% rise. The scrip had also outperformed the market over the past one quarter advancing 32.1% as against the Sensexs 6.1% rise. The scrip had, however, underperformed the market over the past one year advancing 2.73% as against the Sensexs 16.67% rise.

The small-cap company has equity capital of Rs 22.82 crore. Face value per share is Rs 10.

Shares of Nelco had rallied 28.72% in the preceding two trading sessions to settle at Rs 103.30 yesterday, 21 June 2017, from its close of Rs 80.25 on 19 June 2017.

Nelcos consolidated net profit fell 57.21% to Rs 0.98 crore on 1.37% increase in net sales to Rs 36.99 crore in Q4 March 2017 over Q3 December 2016.

Nelco offers solutions in the areas of integrated security & surveillance, VSAT connectivity (Tatanet VSAT), managed services, satcom projects and meteorological solutions. The company offers a range of innovative and customized solutions for businesses and government institutions under one roof.

Powered by Capital Market - Live News

RCom rings loud after initiating monetization of real estates
Jun 22,2017

The announcement was made after market hours yesterday, 21 June 2017.

Meanwhile, the S&P BSE Sensex was up 203.55 points, or 0.65% to 31,487.19. The S&P BSE Mid-Cap index was down 78.64 points, or 0.53% to 14,929.38.

On the BSE, 21.48 lakh shares were traded in the counter so far, compared with average daily volumes of 38.94 lakh shares in the past one quarter. The stock had hit a high of Rs 20.55 and a low of Rs 19.80 so far during the day. The stock had hit a 52-week high of Rs 55.40 on 31 August 2016. The stock had hit a record low of Rs 17.80 on 14 June 2017.

The stock had underperformed the market over the past one month till 21 June 2017, falling 35.46% compared with 2.69% rise in the Sensex. The scrip had also underperformed the market in past one quarter, slumping 48.23% as against Sensexs 6.1% gains. The scrip had also underperformed the market in past one year, dropping 59.28% as against Sensexs 16.67% gains.

The mid-cap company has equity capital of Rs 1244.49 crore. Face value per share is Rs 5.

Reliance Communications (Rcom) clarified with regards to news titled Rcom puts Mumbai, Delhi real estate assets on the block to pare debt, that the company has initiated the monetization programme for its real estate properties.

The stock has risen 13.01% in seven sessions to its ruling price from a close of Rs 18.05 on 13 June 2017. The stock had seen some bargain hunting recently after the plunge saw the stock hitting record low triggered by ratings agencies Moodys and Fitch on 6 June 2017 further downgrading their ratings on the telecom company and warning about its ability to deal with long-term debt.

However, the company on 7 June 2017 disagreed with the recent rating actions by both these agencies, and believed that these rating actions do not reflect the servicing track record of the company.

The rating agencies have not given due credit to the advanced stage of the corporate transactions (Aircel merger and Tower sale) which are expected to deleverage the companys balance sheet by $4 billion i.e. by 60% within the next few months.

The company added that the recent positive development of the standstill period agreed by lenders has been viewed negatively by the rating agencies on certain technical grounds, while in actual fact the same directly addresses their key concerns about the short term liquidity situation.

RCom had announced on 2 June 2017, that it has been engaged in discussions with its lenders to finalise an overall debt resolution plan, with the objective of expeditiously closing the already announced strategic transactions with Aircel and Brookfield, to immediately reduce debt from Rs 45000 crore to approximately Rs 20000 crore; a reduction of 60% or Rs 25000 crore. The lenders have taken note of the advanced stage of implementation of RComs strategic transformation programme involving the transactions for the Wireless and Towers Business.

The lenders have proposed to give time of seven months till December 2017 to complete the above transactions, and reduce its debt by a substantial amount of Rs 25000 crore, or 60%.

On a consolidated basis, Reliance Communications reported net loss of Rs 948 crore in Q4 March 2017 as against net profit of Rs 79 crore in Q4 March 2016. Net sales declined 24.1% to Rs 4312 crore in Q4 March 2017 over Q4 March 2016.

RCom is an integrated telecommunications service provider.

Powered by Capital Market - Live News

Alembic Pharma in pink of health after USFDA nod for drug
Jun 22,2017

The announcement was made before market hours today, 22 June 2017.

Meanwhile, the S&P BSE Sensex was up 135.80 points, or 0.43% to 31,419.44.

On the BSE, 1,362 shares were traded in the counter so far, compared with average daily volumes of 56,242 shares in the past one quarter. The stock had hit a high of Rs 543 and a low of Rs 538.05 so far during the day.

The stock had hit a 52-week high of Rs 709.30 on 23 March 2017. The stock had hit a 52-week low of Rs 517 on 15 June 2017.

The stock had underperformed the market over the past one month till 21 June 2017, falling 11.4% compared with 2.69% rise in the Sensex. The scrip had also underperformed the market in past one quarter, declining 10.69% as against Sensexs 6.1% gains. The scrip had also underperformed the market in past one year, dropping 1.85% as against Sensexs 16.67% gains.

The large-cap company has equity capital of Rs 37.70 crore. Face value per share is Rs 2.

Alembic Pharmaceuticals has received approval from US Food & Drug Administration (USFDA) for its abbreviated new drug application (ANDA) for Amantadine Hydrochloride Capsules, USP, 100 mg. The approved ANDA is therapeutically equivalent to the reference listed drug product Symmetrel Capsules, 100 mg of Endo Pharmaceuticals Inc.

Amantadine Hydrochloride Capsules USP, 100 mg are indicated for the prophylaxis and treatment of signs and symptoms of infection caused by various strains of influenza A virus. The drug is also indicated in the treatment of parkinsonism and drug induced extrapyramidal reactions.

Amantadine Hydrochloride Capsules have an estimated market size of $37 million in US for twelve months ended December 2016 according to IMS.

Alembic Pharmaceuticals had announced during market hours yesterday, 21 June 2017 that the company received approval from the USFDA for its abbreviated new drug application for Candesartan Cilexetil Tablets, 32 mg. Post that news, the stock had risen 1.7% to Rs 531.90 yesterday, 21 June 2017.

Alembic Pharmaceuticals consolidated net profit rose 2.4% to Rs 93.04 crore on 18.3% rise in net sales to Rs 741.35 crore in Q4 March 2017 over Q4 March 2016.

Alembic Pharmaceuticals, a vertically integrated research and development pharmaceutical company, manufactures and markets generic pharmaceutical products all over the world.

Powered by Capital Market - Live News

New order boosts Nila Infra
Jun 22,2017

The announcement was made after market hours yesterday, 21 June 2017.

Meanwhile, the S&P SBE Sensex was up 130.82 points or 0.42% at 31,414.46. The S&P BSE Small-Cap index rose 86.46 points or 0.55% at 15,782.73.

On the BSE, 62,000 shares were traded on the counter so far as against the average daily volumes of 5.59 lakh shares in the past one quarter. The stock had hit a high of Rs 17.95 and a low of Rs 17.60 so far during the day. The stock had hit a record high of Rs 19.90 on 6 February 2017 and a 52-week low of Rs 10.25 on 24 June 2016.

The stock had underperformed the market over the past one month till 21 June 2017, advancing 0.57% compared with the Sensexs 2.69% rise. The stock had, however, outperformed the market over the past one quarter, advancing 8% as against the Sensexs 6.1% rise. The scrip had also outperformed the market over the past one year, gaining 50.13% as against the Sensexs 16.67% rise.

The small-cap company has equity capital of Rs 39.34 crore. Face value per share is Rs 1.

Nila Infrastructures received a work order from Ahmedabad Municipal Corporation (AMC) for the Integrated Slum In-Situ Development for public private partnership (PPP) project of about 360 residential units at Ahmedabad under Urban Development & Urban Housing Department, Government of Gujarats Slum Rehabilitation and Redevelopment Policy-2013.

The redevelopment projects total cost outlay is about Rs 25.16 crore with a timeframe of 24 months. As remuneration, the company will get the balance vacant land of about 1,893 sq. mts worth Rs 7.58 crore and the transferable development rights (TDR) of Rs 17.58 crore.

Nila Infrastructures net profit rose 32.9% to Rs 7.71 crore on 7% growth in net sales to Rs 74.09 crore in Q4 March 2017 over Q4 March 2016.

Nila Infrastructures is engaged in developing civil urban infrastructure projects on EPC, turnkey, PPP mode, as well as private white label construction and industrial infrastructure projects.

Powered by Capital Market - Live News

Goa Carbon retracts from record high on profit booking
Jun 22,2017

Meanwhile, the S&P BSE Sensex was up 135.55 points or 0.43% at 31,419.19. The S&P BSE Small-Cap index rose 89.12 points or 0.57% at 15,785.39.

On the BSE, 2.62 lakh shares were traded on the counter so far as against the average daily volumes of 1.36 lakh shares in the past one quarter. The stock had hit a high of Rs 268.20 so far during the day, which is a record high. The stock hit a low of Rs 254.50 so far during the day. The stock had hit a 52-week low of Rs 85.10 on 21 November 2016.

The stock had outperformed the market over the past one month till 21 June 2017, advancing 82.99% compared with the Sensexs 2.69% rise. The stock had also outperformed the market over the past one quarter, gaining 136.98% as against the Sensexs 6.1% rise. The scrip had also outperformed the market over the past one year, spurting 177.03% as against the Sensexs 16.67% rise.

The small-cap company has equity capital of Rs 9.15 crore. Face value per share is Rs 10.

Shares of Goa Carbon had surged 65.98% in the preceding seven trading sessions to settle at Rs 259.85 yesterday, 21 June 2017, from its close of Rs 156.55 on 12 June 2017.

Meanwhile, shares of Goa Carbon turned ex-dividend today, 22 June 2017, for final dividend of Rs 3 per share for the year ended 31 March 2017.

Goa Carbons net profit spurted 1139% to Rs 5.08 crore on 13.9% increase in net sales to Rs 76.32 crore in Q4 March 2017 over Q4 March 2016.

Goa Carbon is engaged in the business of manufacturing and marketing of calcined petroleum coke.

Powered by Capital Market - Live News

Hindustan Unilever drops ex-dividend
Jun 22,2017

Meanwhile, the S&P BSE Sensex was up 132.06 points, or 0.42% at 31,415.70.

On the BSE, 12,000 shares were traded on the counter so far as against the average daily volumes of 1.32 lakh shares in the past one quarter. The stock had hit a high of Rs 1,118.80 and a low of Rs 1,105 so far during the day. The stock had hit a record high of Rs 1,128 on 21 June 2017 and a 52-week low of Rs 782.95 on 23 December 2016.

The stock had outperformed the market over the past one month till 21 June 2017, advancing 11.53% compared with the Sensexs 2.69% rise. The scrip had also outperformed the market over the past one quarter advancing 24.33% as against the Sensexs 6.1% rise. The scrip had also outperformed the market over the past one year advancing 28.85% as against the Sensexs 16.67% rise.

The large-cap company has equity capital of Rs 216.45 crore. Face value per share is Rs 1.

Before turning ex-dividend, the stock offered a dividend yield of 0.89% based on the closing price of Rs 1,123.70 yesterday, 21 June 2017.

Hindustan Unilevers net profit rose 6.2% to Rs 1183 crore on 6.8% increase in net sales to Rs 8100 crore in Q4 March 2017 over Q4 March 2016.

HUL is a leading fast moving consumer goods (FMCG) company.

Powered by Capital Market - Live News

Federal Bank gains ahead of fixing issue price for QIP
Jun 22,2017

The announcement was made after market hours yesterday, 21 June 2017.

Meanwhile, the S&P BSE Sensex was up 112.12 points or 0.36% at 31,395.76.

On the BSE, 2.16 lakh shares were traded on the counter so far as against the average daily volumes of 10.40 lakh shares in the past one quarter. The stock had hit a high of Rs 119.50 and a low of Rs 117.50 so far during the day. The stock had hit a record high of Rs 122.40 on 16 June 2017 and a 52-week low of Rs 52 on 24 June 2016.

The stock had outperformed the market over the past one month till 21 June 2017, advancing 3.96% compared with the Sensexs 2.69% rise. The stock had also outperformed the market over the past one quarter, gaining 31.59% as against the Sensexs 6.1% rise. The scrip had also outperformed the market over the past one year, surging 106.08% as against the Sensexs 16.67% rise.

The large-cap bank has equity capital of Rs 345.35 crore. Face value per share is Rs 2.

Federal Bank said that a committee meeting will be held on or after 27 June 2017 to consider the issue price of qualified institutional placement (QIP). The QIP opened on 21 June 2017 and floor price of Rs 117.04 per share has been fixed.

Federal Banks net profit surged 2400.9% to Rs 256.59 crore on 14.8% growth in total income to Rs 2598.06 crore in Q4 March 2017 over Q4 March 2016.

Federal Bank is one of the leading private sector banks in India.

Powered by Capital Market - Live News

Prism Cement hardens after JV completes expansion
Jun 22,2017

The announcement was made after market hours yesterday, 21 June 2017.

Meanwhile, the S&P BSE Sensex was up 121.18 points, or 0.39%, to 31,404.82. The S&P BSE Mid-Cap index was up 56.86 points, or 0.38%, to 14,907.60.

On the BSE, 11,248 shares were traded on the counter so far as against the average daily volumes of 1.02 lakh shares in the past one quarter. The stock had hit a high of Rs 121.80 and a low of Rs 119.90 so far during the day. The stock had hit a 52-week high of Rs 129.10 on 28 April 2017. The stock had hit a 52-week low of Rs 72 on 27 December 2016.

The stock had underperformed the market over the past one month till 21 June 2017, falling 2.82% compared with 2.69% rise in the Sensex. The scrip had, however, outperformed the market in past one quarter, gaining 15.77% as against Sensexs 6.1% gains. The scrip had also outperformed the market in past one year, gaining 24.51% as against Sensexs 16.67% gains.

The mid-cap company has equity capital of Rs 503.36 crore. Face value per share is Rs 10.

Prism Cement said that Sanskar Ceramic (Sanskar), a step-down joint venture of the company has successfully completed the expansion of 4.2 million square meters (MSM) per annum vitrified tiles capacity at its Dhuva plant, Morbi, Gujarat. The commercial production has commenced from 21 June 2017.

With this expansion, the company would be able to reduce outsourcing of vitrified tiles from third party sources and become more self-reliant. The capacity of Sanskar now stands at 2.3 MSM of wall tiles and 4.2 MSM of Vitrified Tiles.

The overall capacity of H & R Johnson (India), a division of Prism Cement, along-with its joint ventures and subsidiaries would stand at over 65 MSM per annum.

Prism Cements net profit declined 7.2% to Rs 70.15 crore on 2.3% rise in net sales to Rs 1418.57 crore in Q4 March 2017 over Q4 March 2016.

Prism Cement is an integrated building materials company, with a wide range of products from cement, ready-mixed concrete, tiles, bath products to kitchens. The company has three divisions, viz. Prism Cement, H & R Johnson (India) and RMC Readymix (India).

Powered by Capital Market - Live News

Tata Motors accelerates after committee approves fund raising
Jun 22,2017

The announcement was made after market hours yesterday, 21 June 2017.

Meanwhile, the S&P BSE Sensex was up 124.05 points or 0.4% at 31,407.69.

On the BSE, 21,247 shares were traded on the counter so far as against the average daily volumes of 5.36 lakh shares in the past one quarter. The stock had hit a high of Rs 462.70 and a low of Rs 458 so far during the day.

Tata Motors said that duly authorised committee approved offering for subscription, on a private placement basis, up to 5,000 rated, listed, unsecured, 7.50% coupon, redeemable, non-convertible debentures (NCDs) of face value Rs 10 lakh each, at par, aggregating up to Rs 500 crore.

On 15 June 2017, the company had said that it is desirous of offering the eighth series of its NCDs aggregating to Rs 500 crore and in this regard will hold a meeting of its duly constituted committee of the board on 21 June 2017.

The issuance is pursuant to the approval of the shareholders passed vide special resolution at the 71th Annual General Meeting of the company held on 9 August 2016 and the board of directors resolution passed at its meeting held on 23 May 2017.

On a consolidated basis, net profit of Tata Motors declined 16.8% to Rs 4336.43 crore on 2.9% decline in net sales to Rs 77217.19 crore in Q4 March 2017 over Q4 March 2016.

Tata Motors is a market leader in commercial vehicles in India. The companys British luxury unit Jaguar Land Rover (JLR) sells premium luxury cars.

Powered by Capital Market - Live News

L&T nudges higher on reports of Govts stake sale
Jun 21,2017

Meanwhile, the S&P BSE Sensex was down 16.55 points or 0.05% at 31,280.98.

On the BSE, 2.39 crore shares were traded on the counter so far as against the average daily volumes of 1.97 lakh shares in the past one quarter. The stock had hit a high of Rs 1,781.40 and a low of Rs 1,751.55 so far during the day. The stock had hit a 52-week high of Rs 1,834 on 30 May 2017 and a 52-week low of Rs 1,295.30 on 9 November 2016.

The stock had underperformed the market over the past one month till 20 June 2017, gaining 1.54% compared with the Sensexs 2.73% rise. The stock had, however, outperformed the market over the past one quarter, advancing 13.8% as against the Sensexs 6.03% rise. The scrip had underperformed the market over the past one year, gaining 16.27% as against the Sensexs 16.49% rise.

The large-cap company has equity capital of Rs 186.68 crore. Face value per share is Rs 2.

As per reports, the Government of India (GoI), through the state-owned Specified Undertaking of Unit Trust of India (SUUTI) sold about 2.5% stake in L&T through block deals on the stock exchanges today, 21 June 2017.

SUUTI owned a 6.55% stake in L&T end March 2017.

Meanwhile, media reports suggested that ABB India is in discussions with L&T to acquire the latters electrical and automation division. According to reports, ABB has offered over Rs 14000 crore for the deal and discussions are yet to arrive at a final figure.

In a separate development, NHPC announced after market hours yesterday, 20 June 2017 that it has awarded EPC contract for the development of 50 megawatts (MW) Solar Power project in Tamil Nadu to L&T for an amount of Rs 287.48 crore. The project is slated to complete in 9 months.

L&Ts consolidated net profit rose 28.1% to Rs 3180.41 crore on 12% increase in net sales to Rs 36827.99 crore in Q4 March 2017 over Q4 March 2016.

L&T is a major Indian multinational engaged in technology, engineering, construction, manufacturing and financial services.

Powered by Capital Market - Live News

AstraZeneca moves up after reports of getting marketing nod for drug
Jun 21,2017

Meanwhile, the S&P BSE Sensex was up 28.66 points, or 0.09% to 31,326.19. The S&P BSE Small-Cap index was up 32.04 points, or 0.2% to 15,711.76.

On the BSE, 320 shares were traded in the counter so far, compared with average daily volumes of 4,993 shares in the past one quarter. The stock had hit a high of Rs 930 and a low of Rs 916.65 so far during the day. The stock had hit a 52-week high of Rs 1,146.95 on 24 August 2016. The stock had hit a 52-week low of Rs 909 on 27 February 2017.

The stock had underperformed the market over the past one month till 20 June 2017, falling 4.6% compared with 2.73% rise in the Sensex. The scrip had also underperformed the market in past one quarter, declining 2.26% as against Sensexs 6.03% gains. The scrip had also underperformed the market in past one year, dropping 16.55% as against Sensexs 16.49% gains.

The small-cap company has equity capital of Rs 5 crore. Face value per share is Rs 2.

Symbicort is indicated for treatment of severe asthma and for patients with moderate to severe chronic obstructive pulmonary disease (COPD) with frequent symptoms and a history of exacerbations, report added.

On 15 June 2017, AstraZeneca Pharma India had said it received import and market permission in Form 45 (marketing authorization) from the Drug Controller General of India for fixed-dose combination (FDC) of Budesonide 320 n++g +Formoterol Fumarate Dihydrate 9 n++g inhalation powder.

Astrazeneca Pharma India reported net loss of Rs 2.88 crore in Q4 March 2017 as against net profit of Rs 0.56 crore in Q4 March 2016. Net sales declined 16.90% to Rs 110.95 crore in Q4 March 2017 over Q4 March 2016.

AstraZeneca Pharma India is a subsidiary of AstraZeneca Plc, UK. It covers manufacturing, sales and marketing activities of the company in India. The company has an innovative portfolio in crucial areas of healthcare including cardiovascular and & metabolic diseases, oncology and respiratory.

Powered by Capital Market - Live News